Press "Enter" to skip to content

New patent expiration for Teva Pharm drug AIRDUO RESPICLICK


Annual Drug Patent Expirations for AIRDUO+RESPICLICK
Annual Drug Patent Expirations for AIRDUO+RESPICLICK

Airduo Respiclick is a drug marketed by Teva Pharm
and is included in one NDA. It is available from two suppliers. There are sixteen patents protecting this drug.

This drug has three hundred and seventeen patent family members in thirty-two countries.

The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Two suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!